Fig. 3
From: Amyloid-β1–43 cerebrospinal fluid levels and the interpretation of APP, PSEN1 and PSEN2 mutations
CSF levels of Aβ1–42 and Aβ1–42/Aβ1–40 ratio in the three mutation carrier groups compared to controls. Scatter plots show Aβ1–42 (a) and Aβ1–42/Aβ1–40 (b) CSF levels in controls and in carriers of known pathogenic mutations, of VUS and of PSEN1 p.E318G. Values of mean ± SD are given. p value indicators correspond to the values assessed with Kruskal-Wallis: *p < 0.05, **p < 0.01, ***p < 0.0001